Hyderabad-based HRV Pharma acquires German clinical trial supplier Phatebo, which reported ₹350 crore revenue in 2025, marking its entry into Europe's finished formulations business
HRV Pharma acquires German firm Phatebo, enters finished formulations biz

Hyderabad-based HRV Pharma acquires German clinical trial supplier Phatebo, which reported ₹350 crore revenue in 2025, marking its entry into Europe's finished formulations business
Key Takeaways
- HRV Pharma acquires German firm Phatebo, enters finished formulations biz.
Read Complete Original Article
Published originally on Business Standard - Latest






